Records View

A prospective study to assess the usefulness of 3-dimensional thyroid model on the informed consent and understanding of patients prior to thyroid surgery

Status Approved

  • First Submitted Date

    2020/05/25

  • Registered Date

    2020/05/29

  • Last Updated Date

    2020/12/01

CRIS Required

WHO ICTRP (International Clinical Trial Registry Platform) Required

  • 1. Background

    Background - CRIS Registration Number, Unique Protocol ID, Public/Brief Title, Scientific Title, Acronym, MFDS Regulated Study, IND/IDE Protocol, Registered at Other Registry, Name of Registry/Registration Number
    CRIS
    Registration Number
    KCT0005069
    Unique Protocol ID NCC2019-0256
    Public/Brief Title A study to analysis the usefulness of personalized 3D thyroid model
    Scientific Title A prospective study to assess the usefulness of 3-dimensional thyroid model on the informed consent and understanding of patients prior to thyroid surgery
    Acronym THY3D
    MFDS Regulated Study No
    IND/IDE Protocol No
    Registered at Other Registry No
    Healthcare Benefit Approval Status Not applicable
  • 2. Institutional Review Board / Ethics Committee

    Institutional Review Board Information
    Board Approval Status Submitted approval
    Board Approval Number NCC2019-0256
    Approval Date 2019-11-04
    Institutional Review Board Name National Cancer Center Institutional Review Board
    Institutional Review Board Address 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do
    Institutional Review Board Telephone 031-920-0425
    Data Monitoring Committee No
  • 3. Contact Details

    Contact Details Information - Contact Person for Principal Investigator / Scientific Queries, Contact Person for Public Queries, Contact Person for Updating Information의 Name, Title, Email, Telephone, Cellular Phone, Affiliation, Address
    Contact Person for Principal Investigator / Scientific Queries
    Name Yuh-Seog Jung
    Title Senior Researcher
    Telephone +82-31-920-1685
    Affiliation National Cancer Center
    Address 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do
    Contact Person for Public Queries
    Name Jungirl Seok
    Title Clinical Staff
    Telephone +82-31-920-1625
    Affiliation National Cancer Center
    Address 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do
    Contact Person for Updating Information
    Name Jungirl Seok
    Title Clinical Staff
    Telephone +82-31-920-1625
    Affiliation National Cancer Center
    Address 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do
  • 4. Status

    Status Information - Study Site, Overall Recruitment Status, Date of First Enrollment, Status of First Enrollment, Target Number of Participant, Primary Completion Date, Recruitment Status by Participating Study Site, Name of Study Site, Recruitment Status, Date of First Enrollment, Status of First Enrollemnt
    Study Site Single
    Overall Recruitment Status Completed
    Date of First Enrollment 2020-07-07 Actual
    Target Number of Participant 60
    Primary Completion Date 2020-12-01 , Actual
    Study Completion Date 2020-12-01 , Actual
    Recruitment Status by Participating Study Site 1
    Name of Study National Cancer Center
    Recruitment Status Completed
    Date of First Enrollment 2020-07-07 ,
  • 5. Source of Monetary / Material Support

    Source of Monetary / Material Support Information - Organization Name, Organization Type, Project ID
    1. Source of Monetary/Material Support
    Organization Name National Cancer Center
    Organization Type Medical Institute
    Project ID 1810866-2
  • 6. Sponsor Organization

    Sponsor Organization Information - Organization Name, Organization Type
    1. Sponsor Organization
    Organization Name National Cancer Center
    Organization Type Medical Institute
  • 7. Study Summary

    Study Summary Information
    Lay Summary
    Background: multimedia-based resources were introduced to help patients in understanding their disease. Recently, the use of 3D-printing in medicine has been increased, it enabled us to explain to a patient using a personalized 3D model.
    Purpose: To prospectively evaluate the usefulness of 3D models of the thyroid gland for improving patient understanding of thyroid surgery and disease.
    Subjects included: Patients diagnosed with thyroid cancer or disease who are scheduled for surgery at our institution and who have agreed to a study of thyroid 3D model construction.
    Intervention: Group A randomized by the Block Randomization method uses a 3D model to describe the surgical consent, and Group B receives a description of the operation using only documentation in a conventional manner. A total of two surveys will be given each at the time of receiving a surgical consent (second outpatient visit) and at the date of admission for surgery.
    Outcome Measures: Measure questionnaires evaluated at two different time points: (1) general information about the operation, (2) the need for the operation, (3) the risk of the operation, and (4) satisfaction with the explanation.
    Research hypothesis: There will be an improvement in the understanding of disease, the necessity of risk, the understanding of risk, and overall explanation satisfaction in the group of patients who described surgery through 3D model.
  • 8. Study Design

    Study Design Information - Study Type, Study Purpose, Phase, Intervention Model, Blinding/Masking, Blinded Subject, Allocation, Intervention Type, Intervention Description, Number of Arms, Arm Label, Target Number of Participant, Arm Type, Arm Description
    Study Type Interventional Study
    Study Purpose
    Others
    (Tool used to explain to patient)
    Phase Not applicable
    Intervention Model Parallel  
    Blinding/Masking Single
    Blinded Subject Subject
    Allocation RCT
    Intervention Type Others  
    Intervention Description
    Group A randomly assigned by the Block Randomization method uses a 3D model when explaining a surgical consent form, and Group B receives a description of the surgery using only a document in a conventional manner.
    Number of Arms 2
    Arm 1

    Arm Label

    Arm B

    Target Number of Participant

    30

    Arm Type

    No intervention

    Arm Description

    The second visit after the study consent (first visit) is approved by using the document only in the conventional manner.
    Arm 2

    Arm Label

    Arm A

    Target Number of Participant

    30

    Arm Type

    Experimental

    Arm Description

    On the second visit after the study consent (first visit), a surgical consent is obtained using the 3D model.
  • 9. Subject Eligibility

    Subject Eligibility Information
    Condition(s)/Problem(s) * (C00-D48)Neoplasms 
       (C73)Malignant neoplasm of thyroid gland 

    Cancer of Thyroid Thyroid neoplasms
    Rare Disease No
    Inclusion Criteria

    Gender

    Both

    Age

    20Year~70Year

    Description

    Patients who have been diagnosed with thyroid cancer or disease and are planning to undergo surgery at the research institute, and have consented to the study of thyroid 3D model construction.
    Exclusion Criteria
    Withdrawal of consent at patient's request
    Healthy Volunteers No
  • 10. Outcome Measure(s)

    Outcome Measure(s) Information - Type of Primary Outcome, Primary Outcome, Outcome, Timepoint, Secondary Outcome, Outcome, Timepoint
    Type of Primary Outcome Not applicable
    Primary Outcome(s) 1
    Outcome
    Degree of understanding of the risk of surgery
    Timepoint
    Immediately after receiving a written consent and at the time of admission for surgery
    Primary Outcome(s) 2
    Outcome
    Satisfaction with explaining surgery
    Timepoint
    Immediately after receiving a written consent and at the time of admission for surgery
    Primary Outcome(s) 3
    Outcome
    Degree of understanding of the disease
    Timepoint
    Immediately after receiving a written consent and at the time of admission for surgery
    Primary Outcome(s) 4
    Outcome
    Degree of understanding of the necessity of surgery
    Timepoint
    Immediately after receiving a written consent and at the time of admission for surgery
    Secondary Outcome(s) 1
    Outcome
    Changes in survey scores (primary outcomes) at intervals between two questionnaires
    Timepoint
    At the end of the second questionnaire
  • 11. Study Results and Publication

    Study Results and Publication Information - Result Registered, Final Enrollment Number, Number of Publication, Publications, Results Upload, Date of Posting Results, Protocol URL or File Upload, Brief Summary
    Result Registered No
  • 12. Sharing of Study Data(Deidentified Individual-Patient Data, IPD)

    Sharing of Study Data Information - Sharing Statement, Time of Sharing, Way of Sharing
    Sharing Statement No
화면 최상단으로 이동

TOP

BOTTOM

화면 최하단으로 이동